AbCellera Biologics Inc.ABCLNASDAQ

Revenue (LTM)

$75M

+160.6% YoY

Net Income (LTM)

$-146M

+10.1% YoY

Free Cash Flow

$-174M

Revenue CAGR (5Y)

-20.3%

Marginsimproving

FCF($0.2B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	375	485↑29.4%	38↓92.2%	29↓24.2%	75↑160.6%
Gross Profit	330	419↑27.1%	38↓90.9%	29↓24.2%	75↑160.6%
Operating Income	204	217↑5.9%	-237↓209.6%	-315↓32.7%	-217↑31.0%
Net Income	153	159↑3.3%	-146↓192.4%	-163↓11.2%	-146↑10.1%
EBITDA	239	260↑8.8%	-192↓173.9%	-204↓6.2%	-155↑23.9%
EPS Diluted	0.48	0.50↑4.2%	-0.51↓202.0%	-0.55↓7.8%	-0.49↑10.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	476	387↓18.8%	133↓65.5%	156↑17.3%	155↓0.8%
Total Current Assets	930	1,025↑10.3%	872↓15.0%	751↓13.8%	728↓3.1%
Total Assets	1,319	1,541↑16.9%	1,488↓3.4%	1,361↓8.6%	1,357↓0.3%
Total Current Liabilities	121	118↓2.0%	119↑0.6%	77↓35.6%	64↓16.1%
Total Liabilities	293	308↑5.1%	336↑9.1%	304↓9.3%	216↓29.2%
Total Equity	1,026	1,233↑20.2%	1,152↓6.6%	1,056↓8.4%	1,141↑8.1%
Total Debt	40	82↑105.3%	77↓5.9%	65↓15.5%	143↑119.1%
Net Debt	-436	-304↑30.2%	-56↑81.6%	-91↓62.6%	-12↑87.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	245	277↑13.4%	-44↓115.8%	-109↓147.4%	-131↓20.9%
Capital Expenditure	-58	-73↓24.3%	-78↓6.7%	-78↓1.1%	-43↑45.4%
Free Cash Flow	186	205↑10.0%	-121↓159.3%	-187↓54.0%	-174↑6.9%
Stock-Based Comp	31	49↑61.5%	64↑29.7%	68↑5.3%	56↓17.4%
Net Change in Cash	-93	-86↑7.0%	-254↓193.7%	23↑109.1%	-28↓223.3%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance